ASMB — Assembly Biosciences Share News
0.000.00%
Last trade - 00:00- $403.95m
- $83.59m
- $72.30m
U.S. STOCKS ON THE MOVE-Meten, nCino, American Eagle, pharma stocks
Assembly Bio's other Hep B programs unaffected despite drug failure - analysts
U.S. STOCKS ON THE MOVE-American Eagle, Meten, Barnes & Noble, pharma stocks
Assembly Bio scraps development of hep B drug; stock set for record low
Brief: Assembly Bio Announces Decision To Discontinue Clinical Development Of AbI-H2158
Brief: Assembly Bio Selects Fourth Hbv Core Inhibitor Candidate For Advancement Into Clinical Development
Assembly Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Assembly Biosciences Inc expected to post a loss of 66 cents a share - Earnings Preview
Brief: Assembly Biosciences Inc - With Michael Houghton’S Appointment To Board, Size Of Board Increased From Eight Directors To Nine Directors
Brief: Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors
Brief: Assembly Biosciences Says CFO Thomas Russo To Resign Effective June 4
Brief: Lisa Johnson-Pratt Joins Assembly Biosciences Board Of Directors
Brief: Assembly Biosciences Reports First Quarter 2021 Financial Results And Recent Updates
U.S. RESEARCH ROUNDUP-Athenex, Satsuma Pharmaceuticals, Viatris
Arbutus Biopharma: Rises as mid-stage hepatitis B treatment study starts
Brief: Assembly Biosciences And Arbutus Biopharma Initiate Phase 2 Clinical Trial Of Triple Combination Therapy For The Treatment Of Chronic Hepatitis B Virus
U.S. RESEARCH ROUNDUP- Editas Medicine, HP, LivePerson
Brief: Assembly Biosciences Reports Q4 Loss Per Share Of $1.10
Brief: Assembly Biosciences Updates Pipeline Strategy